New Jersey Patent of the Month – September 2024
electroCore, Inc. has developed a groundbreaking non-invasive device that uses electrical stimulation to treat various medical conditions by targeting the vagus nerve. This innovative approach offers a safer alternative to traditional therapies, which often involve surgery or medications with significant side effects. By delivering controlled electrical impulses transcutaneously, or through the skin, near the vagus nerve, the device modulates nerve activity to trigger beneficial physiological responses.
The electrical pulses generated by the device are designed to stimulate dopamine-producing neurons and release inhibitory neurotransmitters, such as GABA or glutamate, in the brain. This modulation can also activate the body’s natural production of opioids and cannabinoids, providing relief from conditions like migraines, cluster headaches, and even anxiety. The beauty of this system is that it achieves these effects without the need for invasive procedures or reliance on pharmaceuticals, reducing the risks of dependency or adverse reactions.
The device is compact, with electrodes placed on the outer surface of the neck, and it operates in controlled bursts of electrical impulses ranging from 5 to 100 Hz. This targeted stimulation of the vagus nerve helps balance the nervous system, offering a therapeutic option for patients who suffer from hyper-reactive nerve conditions that often overlap with other issues like asthma or sinus headaches.
electroCore’s innovation represents a significant leap forward in neuromodulation therapy. With this non-invasive, user-friendly device, patients can experience relief from chronic conditions in a way that is safe, reversible, and free from the complications often associated with traditional treatments. This technology opens new doors for treating neurological disorders in a more holistic, side-effect-free manner.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
